USD 42.46
(-1.32%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.35 Billion USD | 8.45% |
2022 | 956.3 Million USD | 169.17% |
2021 | 355.27 Million USD | 24.73% |
2020 | 284.83 Million USD | 31.61% |
2019 | 216.42 Million USD | 5.27% |
2018 | 205.58 Million USD | 58.04% |
2017 | 130.08 Million USD | 6.08% |
2016 | 122.62 Million USD | 0.76% |
2015 | 121.7 Million USD | 6.68% |
2014 | 114.08 Million USD | 11.36% |
2013 | 102.44 Million USD | 19.66% |
2012 | 85.61 Million USD | 4.4% |
2011 | 81.99 Million USD | 11.19% |
2010 | 73.74 Million USD | 36.51% |
2009 | 54.02 Million USD | 9.56% |
2008 | 49.3 Million USD | -1.4% |
2007 | 50 Million USD | 5.58% |
2006 | 47.36 Million USD | -21.7% |
2005 | 60.48 Million USD | 45.26% |
2004 | 41.64 Million USD | 6.7% |
2003 | 39.02 Million USD | 12.99% |
2002 | 34.54 Million USD | -1.48% |
2001 | 35.05 Million USD | 2.47% |
2000 | 34.21 Million USD | 0.0% |
1998 | 27 Million USD | 1.12% |
1997 | 26.7 Million USD | 14.1% |
1996 | 23.4 Million USD | 16.42% |
1995 | 20.1 Million USD | -3.37% |
1994 | 20.8 Million USD | 18.86% |
1993 | 17.5 Million USD | 20.69% |
1992 | 14.5 Million USD | 10.69% |
1991 | 13.1 Million USD | -32.12% |
1990 | 19.3 Million USD | 271.15% |
1989 | 5.2 Million USD | -16.13% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 271.9 Million USD | 10.13% |
2024 Q2 | 253.8 Million USD | -6.66% |
2023 Q2 | 299.1 Million USD | -6.33% |
2023 Q1 | 319.3 Million USD | -5.0% |
2023 FY | 1.03 Billion USD | 8.45% |
2023 Q3 | 315.3 Million USD | 5.42% |
2023 Q4 | 246.9 Million USD | -21.69% |
2022 FY | 956.3 Million USD | 169.17% |
2022 Q1 | 116.26 Million USD | 10.93% |
2022 Q2 | 177.6 Million USD | 52.76% |
2022 Q3 | 324.3 Million USD | 82.6% |
2022 Q4 | 336.1 Million USD | 3.64% |
2021 Q4 | 104.81 Million USD | 14.46% |
2021 FY | 355.27 Million USD | 24.73% |
2021 Q2 | 81.85 Million USD | 6.24% |
2021 Q3 | 91.56 Million USD | 11.87% |
2021 Q1 | 77.04 Million USD | -8.17% |
2020 Q1 | 61.44 Million USD | 7.38% |
2020 Q4 | 83.89 Million USD | 11.46% |
2020 FY | 284.83 Million USD | 31.61% |
2020 Q3 | 75.27 Million USD | 17.22% |
2020 Q2 | 64.21 Million USD | 4.5% |
2019 FY | 216.42 Million USD | 5.27% |
2019 Q2 | 51.52 Million USD | -9.53% |
2019 Q1 | 56.95 Million USD | 10.97% |
2019 Q4 | 57.22 Million USD | 12.83% |
2019 Q3 | 50.72 Million USD | -1.56% |
2018 FY | 205.58 Million USD | 58.04% |
2018 Q1 | 51.71 Million USD | 13.01% |
2018 Q3 | 50.22 Million USD | -4.02% |
2018 Q2 | 52.32 Million USD | 1.2% |
2018 Q4 | 51.32 Million USD | 2.18% |
2017 Q1 | 30.89 Million USD | 11.23% |
2017 FY | 130.08 Million USD | 6.08% |
2017 Q4 | 45.75 Million USD | 55.37% |
2017 Q3 | 29.44 Million USD | 0.99% |
2017 Q2 | 29.16 Million USD | -5.61% |
2016 Q3 | 29.48 Million USD | -4.37% |
2016 FY | 122.62 Million USD | 0.76% |
2016 Q4 | 27.77 Million USD | -5.81% |
2016 Q1 | 34.53 Million USD | 9.18% |
2016 Q2 | 30.83 Million USD | -10.71% |
2015 Q2 | 29.2 Million USD | -7.29% |
2015 FY | 121.7 Million USD | 6.68% |
2015 Q3 | 28.63 Million USD | -1.94% |
2015 Q1 | 31.5 Million USD | 7.08% |
2015 Q4 | 31.62 Million USD | 10.44% |
2014 Q4 | 29.41 Million USD | -4.02% |
2014 Q2 | 25.57 Million USD | -10.63% |
2014 Q1 | 28.61 Million USD | -4.91% |
2014 FY | 114.08 Million USD | 11.36% |
2014 Q3 | 30.65 Million USD | 19.87% |
2013 Q1 | 25.25 Million USD | 13.72% |
2013 Q3 | 24.08 Million USD | 4.01% |
2013 FY | 102.44 Million USD | 19.66% |
2013 Q4 | 30.09 Million USD | 24.94% |
2013 Q2 | 23.15 Million USD | -8.32% |
2012 Q3 | 19.34 Million USD | -9.46% |
2012 Q2 | 21.36 Million USD | -5.79% |
2012 Q1 | 22.68 Million USD | 8.18% |
2012 FY | 85.61 Million USD | 4.4% |
2012 Q4 | 22.21 Million USD | 14.8% |
2011 Q4 | 20.96 Million USD | 8.32% |
2011 Q1 | 21.6 Million USD | 17.43% |
2011 FY | 81.99 Million USD | 11.19% |
2011 Q2 | 20.07 Million USD | -7.09% |
2011 Q3 | 19.35 Million USD | -3.57% |
2010 Q1 | 17.49 Million USD | 14.22% |
2010 Q4 | 18.39 Million USD | -1.97% |
2010 Q3 | 18.76 Million USD | -2.28% |
2010 Q2 | 19.2 Million USD | 9.79% |
2010 FY | 73.74 Million USD | 36.51% |
2009 Q4 | 15.31 Million USD | 7.64% |
2009 Q2 | 12.38 Million USD | 2.32% |
2009 Q1 | 12.09 Million USD | 10.83% |
2009 Q3 | 14.22 Million USD | 14.92% |
2009 FY | 54.02 Million USD | 9.56% |
2008 Q1 | 13.17 Million USD | 12.9% |
2008 FY | 49.3 Million USD | -1.4% |
2008 Q4 | 10.91 Million USD | -12.29% |
2008 Q3 | 12.44 Million USD | -2.51% |
2008 Q2 | 12.76 Million USD | -3.11% |
2007 FY | 50 Million USD | 5.58% |
2007 Q2 | 12.42 Million USD | -6.14% |
2007 Q4 | 11.67 Million USD | -7.88% |
2007 Q3 | 12.67 Million USD | 1.96% |
2007 Q1 | 13.23 Million USD | 4.89% |
2006 FY | 47.36 Million USD | -21.7% |
2006 Q4 | 12.62 Million USD | 10.94% |
2006 Q3 | 11.37 Million USD | -5.27% |
2006 Q2 | 12.01 Million USD | 5.78% |
2006 Q1 | 11.35 Million USD | -4.48% |
2005 Q1 | 28.94 Million USD | 203.39% |
2005 Q4 | 11.88 Million USD | 26.12% |
2005 Q3 | 9.42 Million USD | -7.92% |
2005 Q2 | 10.23 Million USD | -64.64% |
2005 FY | 60.48 Million USD | 45.26% |
2004 Q1 | 9.59 Million USD | -10.52% |
2004 FY | 41.64 Million USD | 6.7% |
2004 Q2 | 10.85 Million USD | 13.05% |
2004 Q3 | 11.65 Million USD | 7.38% |
2004 Q4 | 9.54 Million USD | -18.13% |
2003 Q3 | 8.79 Million USD | -4.79% |
2003 Q4 | 10.72 Million USD | 22.03% |
2003 Q2 | 9.23 Million USD | -10.19% |
2003 Q1 | 10.27 Million USD | 5.37% |
2003 FY | 39.02 Million USD | 12.99% |
2002 FY | 34.54 Million USD | -1.48% |
2002 Q4 | 9.75 Million USD | 15.36% |
2002 Q1 | 8.38 Million USD | -13.96% |
2002 Q2 | 7.94 Million USD | -5.14% |
2002 Q3 | 8.45 Million USD | 6.38% |
2001 Q3 | 7.87 Million USD | -7.21% |
2001 Q4 | 9.74 Million USD | 23.7% |
2001 FY | 35.05 Million USD | 2.47% |
2001 Q1 | 8.95 Million USD | 15.64% |
2001 Q2 | 8.48 Million USD | -5.28% |
2000 Q3 | 8.83 Million USD | 7.0% |
2000 Q4 | 7.74 Million USD | -12.28% |
2000 Q1 | 11.08 Million USD | 0.0% |
2000 FY | 34.21 Million USD | 0.0% |
2000 Q2 | 8.25 Million USD | -25.53% |
1999 Q2 | 6.2 Million USD | -16.22% |
1999 Q1 | 7.4 Million USD | 10.45% |
1999 Q3 | 9.1 Million USD | 46.77% |
1998 FY | 27 Million USD | 1.12% |
1998 Q1 | 7.7 Million USD | 22.22% |
1998 Q2 | 6.1 Million USD | -20.78% |
1998 Q4 | 6.7 Million USD | -2.9% |
1998 Q3 | 6.9 Million USD | 13.11% |
1997 Q2 | 6.1 Million USD | -1.61% |
1997 Q4 | 6.3 Million USD | -3.08% |
1997 FY | 26.7 Million USD | 14.1% |
1997 Q1 | 6.2 Million USD | 6.9% |
1997 Q3 | 6.5 Million USD | 6.56% |
1996 FY | 23.4 Million USD | 16.42% |
1996 Q4 | 5.8 Million USD | 1.75% |
1996 Q3 | 5.7 Million USD | 0.0% |
1996 Q2 | 5.7 Million USD | 11.76% |
1996 Q1 | 5.1 Million USD | 2.0% |
1995 Q1 | 7.2 Million USD | 56.52% |
1995 Q2 | 5.1 Million USD | -29.17% |
1995 Q3 | 4.9 Million USD | -3.92% |
1995 Q4 | 5 Million USD | 2.04% |
1995 FY | 20.1 Million USD | -3.37% |
1994 FY | 20.8 Million USD | 18.86% |
1994 Q4 | 4.6 Million USD | 2.22% |
1994 Q3 | 4.5 Million USD | 2.27% |
1994 Q2 | 4.4 Million USD | -46.99% |
1994 Q1 | 8.3 Million USD | 124.32% |
1993 Q1 | 4.2 Million USD | 20.0% |
1993 Q4 | 3.7 Million USD | 2.78% |
1993 FY | 17.5 Million USD | 20.69% |
1993 Q3 | 3.6 Million USD | -5.26% |
1993 Q2 | 3.8 Million USD | -9.52% |
1992 Q4 | 3.5 Million USD | 0.0% |
1992 Q1 | 3.7 Million USD | 23.33% |
1992 Q2 | 3.4 Million USD | -8.11% |
1992 Q3 | 3.5 Million USD | 2.94% |
1992 FY | 14.5 Million USD | 10.69% |
1991 Q4 | 3 Million USD | 42.86% |
1991 Q1 | -33 Million USD | 0.0% |
1991 FY | 13.1 Million USD | -32.12% |
1991 Q2 | 2.4 Million USD | 107.27% |
1991 Q3 | 2.1 Million USD | -12.5% |
1990 Q2 | - USD | 100.0% |
1990 Q1 | -8.9 Million USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1990 FY | 19.3 Million USD | 271.15% |
1990 Q3 | - USD | 0.0% |
1989 FY | 5.2 Million USD | -16.13% |
1989 Q1 | -11.5 Million USD | 0.0% |
1989 Q2 | - USD | 100.0% |
1989 Q4 | - USD | 0.0% |
1989 Q3 | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Akoya Biosciences, Inc. | 104.27 Million USD | -1199.799% |
AngioDynamics, Inc. | 252.41 Million USD | -436.931% |
AtriCure, Inc. | 327.05 Million USD | -314.398% |
Avinger, Inc. | 18.63 Million USD | -7171.703% |
Azenta, Inc. | 336.26 Million USD | -303.044% |
BioLife Solutions, Inc. | 117.57 Million USD | -1052.691% |
The Cooper Companies, Inc. | 1.82 Billion USD | 25.729% |
Daxor Corporation | 1.28 Million USD | -105740.228% |
Ekso Bionics Holdings, Inc. | 24.19 Million USD | -5502.497% |
Femasys Inc. | 15.2 Million USD | -8816.262% |
GlucoTrack, Inc. | 7.1 Million USD | -18977.984% |
Harvard Bioscience, Inc. | 58.58 Million USD | -2213.549% |
Hologic, Inc. | 1.34 Billion USD | -0.751% |
ICU Medical, Inc. | 717.04 Million USD | -89.011% |
Intuitive Surgical, Inc. | 2.96 Billion USD | 54.255% |
KORU Medical Systems, Inc. | 26.1 Million USD | -5091.155% |
LeMaitre Vascular, Inc. | 90.33 Million USD | -1400.271% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 1135867.5% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 1135867.5% |
Masimo Corporation | 867 Million USD | -56.321% |
Microbot Medical Inc. | 9.85 Million USD | -13652.41% |
Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -7257.738% |
Merit Medical Systems, Inc. | 459.92 Million USD | -194.677% |
Nephros, Inc. | 9.78 Million USD | -13752.208% |
NovoCure Limited | 613.92 Million USD | -120.759% |
NEXGEL, Inc. | 4.09 Million USD | -32988.379% |
NEXGEL, Inc. | 4.09 Million USD | -32988.379% |
Singular Genomics Systems, Inc. | 102.24 Million USD | -1225.568% |
OraSure Technologies, Inc. | 125.34 Million USD | -981.282% |
Pro-Dex, Inc. | 7.37 Million USD | -18269.477% |
Pulse Biosciences, Inc. | 43.57 Million USD | -3010.341% |
Predictive Oncology Inc. | 15.22 Million USD | -8799.158% |
Precision Optics Corporation, Inc. | 8.52 Million USD | -15803.338% |
Repligen Corporation | 261.12 Million USD | -419.027% |
Sanara MedTech Inc. | 61.12 Million USD | -2117.181% |
STAAR Surgical Company | 224.55 Million USD | -503.552% |
Sharps Technology, Inc. | 10.12 Million USD | -13283.498% |
Utah Medical Products, Inc. | 13.26 Million USD | -10120.195% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 24.454% |
Jin Medical International Ltd. | 3.91 Million USD | -34495.408% |